Rogers April J, Kaplan Ian, Chung Alicia, McFarlane Samy I, Jean-Louis Girardin
St. John's University, Division of Health and Human Services, College of Professional Studies, Queens, New York, USA.
SUNY Down State Medical, Department of Internal Medicine Center Brooklyn, New York, USA.
Int J Clin Res Trials. 2020;5(1). doi: 10.15344/2456-8007/2020/143. Epub 2020 Feb 26.
The American Stroke Association estimates that stroke is the fifth leading cause of death in the United States. According to the Center for Disease Control and Prevention someone in the United States has a stoke every 40 seconds, affecting more than 795,000 people of which 140,000 result in death [1]. Emerging evidence suggests that obstructive sleep apnea (OSA) is a strong risk factor for stroke. This study using The Metabolic Syndrome Outcome (MetSO) registry explored whether blacks at risk for obstructive sleep apnea (OSA) are at greater risk for a stroke.
The present study utilized data from the MetSO study, an NIH-funded cohort study of blacks with metabolic syndrome (MetS). Patients were diagnosed with MetS using standard criteria articulated in the joint interim statement for harmonizing the MetS. The study assessed OSA risk using the Apnea Risk Evaluation System (ARES); defining high risk as a total ARES score ≥6. Data was coded and analyzed by an experienced statistician using SPSS 20.0.
A total of 1035 participants were screened for MetS in the MetSO registry. During the data collection period 875 participants were enrolled during the time of analysis. The average age of the sample was 62±14 years (range: 20-97); 71% were female, and all were of black race/ethnicity. Seventy-one percent reported finishing high school, and 43% reported annual income <10K. Descriptive analyses showed 93% of the participants were diagnosed with hypertension; 61%, diabetes; 72%, dyslipidemia; 90% were overweight/obese; 33% had a history of heart disease and 10% had a stroke history. Using the ARES screener, we estimated that 48% were at high risk for OSA. Logistic regression analysis, adjusting for age and gender, showed that patients at high risk for OSA had a nearly three-fold increase in the odds of having a stroke (OR = 2.79, 95% CI: 1.64-4.73).
In the MetSO registry, a cohort of blacks with MetS, the prevalence of stroke is greater than in the general US population. Blacks at risk for OSA are particularly vulnerable to experiencing a stroke.
美国心脏协会估计,中风是美国第五大死因。根据疾病控制与预防中心的数据,美国每40秒就有一人中风,受影响人数超过79.5万,其中14万导致死亡[1]。新出现的证据表明,阻塞性睡眠呼吸暂停(OSA)是中风的一个重要危险因素。本研究使用代谢综合征结局(MetSO)登记处的数据,探讨有阻塞性睡眠呼吸暂停(OSA)风险的黑人是否中风风险更高。
本研究利用了MetSO研究的数据,这是一项由美国国立卫生研究院资助的针对患有代谢综合征(MetS)的黑人的队列研究。根据代谢综合征联合临时声明中阐明的标准对患者进行代谢综合征诊断。该研究使用呼吸暂停风险评估系统(ARES)评估OSA风险;将总ARES评分≥6定义为高风险。数据由一位经验丰富的统计学家使用SPSS 20.0进行编码和分析。
在MetSO登记处共筛选出1035名代谢综合征参与者。在数据收集期间,875名参与者在分析时被纳入。样本的平均年龄为62±14岁(范围:20 - 97岁);71%为女性,且均为黑人种族/族裔。71%的人报告完成了高中学业,43%的人报告年收入<10000美元。描述性分析显示,93%的参与者被诊断患有高血压;61%患有糖尿病;72%患有血脂异常;90%超重/肥胖;33%有心脏病史,10%有中风史。使用ARES筛查工具,我们估计48%的人有OSA高风险。在对年龄和性别进行调整的逻辑回归分析中,OSA高风险患者中风几率增加近三倍(OR = 2.79,95% CI:1.64 - 4.73)。
在MetSO登记处,一组患有代谢综合征的黑人中,中风患病率高于美国普通人群。有OSA风险的黑人尤其容易中风。